Clinical Trials Logo

Filter by:
NCT ID: NCT00526149 Completed - Breast Cancer Clinical Trials

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Start date: July 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: BI 2536 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying the side effects and how well BI 2536 works in treating patients with recurrent or metastatic solid tumors.

NCT ID: NCT00526136 Completed - Atrial Fibrillation Clinical Trials

Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study

Start date: March 2007
Phase: Phase 2
Study type: Interventional

To evaluate the safety, tolerability and efficacy of 3 doses of vernakalant (oral) (150 mg, 300 mg and 500 mg b.i.d.) administered for up to 90 days in subjects with sustained symptomatic atrial fibrillation (AF duration > 72 hours and < 6 months).

NCT ID: NCT00525213 Completed - Clinical trials for Rheumatoid Arthritis

Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate

ROBUST
Start date: October 2007
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the efficacy (ACR20) of Rob 803 administered orally once daily for 12 weeks in combination with a stable dose of methotrexate in subjects with moderate or severe active RA.

NCT ID: NCT00525187 Completed - Clinical trials for Diagnostic of Onychomycosis

Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients

Start date: December 2000
Phase: N/A
Study type: Observational

The prevalence of onychomycosis among diabetic patients is still a debated question as well as the best way to diagnose the disease. We conducted a prospective study to assess the prevalence of onychomycosis in diabetic neuropathic (DN) patients clinically suspected of this disease and to assess the reliability of the diagnosis of onychomycosis.

NCT ID: NCT00524576 Completed - Hepatitis B Clinical Trials

Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine

Start date: November 28, 2007
Phase: Phase 4
Study type: Interventional

To evaluate the response to an additional dose (challenge dose) of hepatitis B vaccine, when given to subjects who had received primary vaccination of Engerix™-B vaccine approximately 72-78 months ago. This protocol posting deals with objectives & outcome measures of the challenge phase. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

NCT ID: NCT00523991 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

Start date: April 2007
Phase: Phase 4
Study type: Interventional

A 24 week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 18mcg of tiotropium inhalation capsules administered by Handihaler once daily plus Pro Re Nata (PRN) albuterol (salbutamol) vs. placebo plus PRN albuterol (salbutamol) in chronic obstructive pulmonary disease subjects naive to maintenance therapy.

NCT ID: NCT00522730 Completed - Critical Illness Clinical Trials

Safety and Tolerance on Lipids of Parenteral and Enteral Nutrition in Critically Ill Patients With Liver Failure

SELLIFA
Start date: August 2007
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the tolerance on lipid metabolism and the safety of short-term parenteral nutrition as compared to enteral nutrition in critically ill patients with liver failure.

NCT ID: NCT00522587 Completed - Anesthesia Clinical Trials

Sevoflurane-Remifentanil Interaction: Multiple Response Surfaces, Validation of Calibration Stimuli, Validation of the Intraoperative Isobole Concept and Investigating Remifentanil Induced Opioid Tolerance

Start date: April 2008
Phase: Phase 2
Study type: Interventional

During this study, the pharmacodynamic interactions between sevoflurane and remifentanil will be studied.

NCT ID: NCT00521625 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury

PALIVE1
Start date: June 2007
Phase: N/A
Study type: Observational

PALIVE 1 is an observational multicenter study on mechanical ventilation strategies used in children with an acute lung injury (ALI). The objective of the study is to describe mechanical ventilation strategies in children with an ALI. Our hypothesis is that daily clinical practice is heterogenous among pediatric intensivists as few pediatric data exists on optimal mechanical ventilation strategies in this group of patients. Furthermore, different strategies may affect patient outcome.

NCT ID: NCT00520572 Completed - Clinical trials for Rheumatoid Arthritis

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

Start date: August 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to confirm that AZD9056 is effective in treating rheumatoid arthritis with regard to signs and symptoms and to determine what dose is favourable over a 6-month treatment period. Patients will receive background treatment with either Methotrexate or Sulphasalazine